Accordingly, siRNA-mediated knockdown of BDNF-AS in ARPE-19 cells alleviated glucose-induced elevations in cell apoptosis and reductions in BDNF levels; thereby, conferring protection to RGCs against diabetes-associated damage. The gene discussed is BDNF; the disease is diabetes mellitus.